2000
DOI: 10.1002/1529-0131(200009)43:9<2064::aid-anr18>3.0.co;2-z
|View full text |Cite
|
Sign up to set email alerts
|

Suppression of streptococcal cell wall–induced arthritis by human chorionic gonadotropin

Abstract: These findings indicate that HCG exerts a protective effect in this experimental arthritis model, through modulation of inflammatory mediators.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0
1

Year Published

2002
2002
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 45 publications
0
17
0
1
Order By: Relevance
“…TGF-β1 has been shown to be therapeutic in several different animal models when expressed systemically from muscle tissue [26,27]. This suggests that elevated serum levels of TGF-β1 can reduce general inflammation as well as inhibit IL-1β and tumor necrosis factor alpha production, resulting in a systemic therapeutic effect.…”
Section: Discussionmentioning
confidence: 99%
“…TGF-β1 has been shown to be therapeutic in several different animal models when expressed systemically from muscle tissue [26,27]. This suggests that elevated serum levels of TGF-β1 can reduce general inflammation as well as inhibit IL-1β and tumor necrosis factor alpha production, resulting in a systemic therapeutic effect.…”
Section: Discussionmentioning
confidence: 99%
“…This suggests that hCG may also exert its protective effect on Tg26 mice by suppressing TNF-␣-induced activation pathways. Similarly, the suppression of streptococcus cell wall-induced arthritis by hCG may be mediated through the reduction of TNF-␣ levels (33). Evidence that hCG actually can suppress TNF-␣-induced pathways, particularly NF-B and AP-1, was recently provided by Manna and colleagues (22).…”
Section: Tnf-␣ Levels In Sera Of Anti-tnf-␣-and Hcg-treated Micementioning
confidence: 99%
“…We used the HPA-1(24-45) peptide and also a shorter peptide with an extended N-terminal sequence (20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39) in both the Leu33 (HPA-1a) and Pro33 (HPA-1b) forms in T cell proliferation assays to detect responding T cells from women who had been alloimmunized by pregnancy. Most samples were taken from patients during pregnancy or postpartum.…”
Section: Introductionmentioning
confidence: 99%